The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

Dextenza is an intracanalicular insert that delivers a 0.4mg dose of dexamethasone, a corticosteroid, for up to 30 days following insertion.

The white fluff floating in the air like snow is causing problems for many, as it tends to trap allergens such as pollen and ...

Aldeyra Therapeutics, Inc.’s ALDX share price has surged by 12.83%, which has investors questioning if this is right time to sell.

ITCHY eyes, constant sneezing, a runny nose… all signs hay fever season is well and truly here. Yep, that joyous time of the ...

Allergic conjunctivitis is a collection of common conditions observed more frequently in industrialized countries. These diseases range in severity from mild – interfering with quality of life ...

Bhopal (Madhya Pradesh): Doctors have warned people for protection of eyes in summer as conjunctivitis, also known as pink ...

The inducement equity awards were granted effective as of April 7, 2025 and consist of (i) for Mr. Cella, a non-statutory ...

This is what your eyes may look like depending on which of the conditions you’re experiencing: Share on Pinterest Pink eye often causes purulent discharge. Viruses, bacteria, or allergies can ...